<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="152">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 24, 2013</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01067196</url>
  </required_header>
  <id_info>
    <org_study_id>UFPTI 0903-CN01</org_study_id>
    <nct_id>NCT01067196</nct_id>
  </id_info>
  <brief_title>Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and Neck</brief_title>
  <acronym>CN01</acronym>
  <official_title>A Study of Late Effects After Proton Radiotherapy for Pediatric Tumors of the Brain, Head, and Neck</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Florida</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect information from medical records to see what effects
      proton beam radiation has on cancer and analyze possible side effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data collection will be obtained from the patient's medical records including initial
      evaluation, radiotherapy completion records and follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">January 2028</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Measure late effects of proton therapy on pediatric patients with CNS tumors</measure>
    <time_frame>5.4 years after treatment completion</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival endpoints of local control, progression-free survival, and overall and cause-specific survival.</measure>
    <time_frame>12 years after treatment completion</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Central Nervous System Tumors</condition>
  <arm_group>
    <arm_group_label>Observation and quality of life</arm_group_label>
    <description>Central Nervous System Tumors</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated at a radiation oncology clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Estimated &gt;5 cc of the brain tissue to receive &gt;5 CGE radiation

          -  Patient must be less than 21 years of age at time of consent.

          -  Patients that require localized and craniospinal irradiation.

        Exclusion Criteria:

          -  Prior radiation therapy.

          -  Evidence of metastases outside the central nervous system.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>20 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel J. Indelicato, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Florida Proton Therapy Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Intake Coordinator</last_name>
    <phone>877-686-6009</phone>
  </overall_contact>
  <location>
    <facility>
      <name>University of Florida Proton Therapy Institute</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Intake Coordinator</last_name>
      <phone>877-686-6009</phone>
    </contact>
    <investigator>
      <last_name>Daniel J. Indelicato, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.floridaproton.org/contact/contact.html</url>
    <description>Contact the University of Florida Proton Therapy Institute</description>
  </link>
  <reference>
    <citation>Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993 Jun 17;328(24):1725-31.</citation>
    <PMID>8388548</PMID>
  </reference>
  <reference>
    <citation>Sklar CA, Constine LS. Chronic Neuroendocrinological Sequelae of Radiation Therapy. Int. J. Radiation Oncology Biol. Phys. 1995; 31(5):1113-21</citation>
  </reference>
  <reference>
    <citation>Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002 Apr 1;94(7):2090-106.</citation>
    <PMID>11932914</PMID>
  </reference>
  <reference>
    <citation>Bhat SR, Goodwin TL, Burwinkle TM, Lansdale MF, Dahl GV, Huhn SL, Gibbs IC, Donaldson SS, Rosenblum RK, Varni JW, Fisher PG. Profile of daily life in children with brain tumors: an assessment of health-related quality of life. J Clin Oncol. 2005 Aug 20;23(24):5493-500.</citation>
    <PMID>16110009</PMID>
  </reference>
  <reference>
    <citation>Huang E, Teh BS, Strother DR, Davis QG, Chiu JK, Lu HH, Carpenter LS, Mai WY, Chintagumpala MM, South M, Grant WH 3rd, Butler EB, Woo SY. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):599-605.</citation>
    <PMID>11849779</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 9, 2013</lastchanged_date>
  <firstreceived_date>February 9, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Proton Radiation</keyword>
  <keyword>Central Nervous System Tumors</keyword>
  <keyword>Brain</keyword>
  <keyword>Spine</keyword>
  <keyword>Cancer</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Brain Neoplasms</mesh_term>
    <mesh_term>Nervous System Neoplasms</mesh_term>
    <mesh_term>Central Nervous System Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
